Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03999710
What this trial is testing

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung CancerNsclc+2 more
Memorial Sloan Kettering Cancer Center 61
Not applicableStudy completedNCT00185913
What this trial is testing

Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

Who this might be right for
Lung Cancer
Stanford University 50
Testing effectiveness (Phase 2)Study completedNCT00951613
What this trial is testing

NK012 in Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Nippon Kayaku Co., Ltd. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Not applicableNot Yet RecruitingNCT07442890
What this trial is testing

A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron

Who this might be right for
Lung Cancer
Henan Cancer Hospital 238
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06537297
What this trial is testing

Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 30
Early research (Phase 1)Looking for participantsNCT07755397
What this trial is testing

First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

Who this might be right for
NSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck
Jubilant Therapeutics India Limited 30
Not applicableUnknownNCT00899613
What this trial is testing

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
University Hospital, Caen 270
Testing effectiveness (Phase 2)Looking for participantsNCT06515990
What this trial is testing

DM005 in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and NeckSolid Carcinoma
Doma Biopharmaceutical（Suzhou）Co., Ltd. 208
Not applicableWithdrawnNCT05426213
What this trial is testing

Robot-Assisted Bronchoscopy in Chinese Participants With Lung Lesions

Who this might be right for
Lung Neoplasms
Auris Health, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT02025218
What this trial is testing

Iressa Re-challenge in Advanced NSCLC EGFR-mutated Patients

Who this might be right for
Lung Cancer
Amsterdam UMC, location VUmc 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05186974
What this trial is testing

Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Gilead Sciences 193
Large-scale testing (Phase 3)Study completedNCT01661790
What this trial is testing

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Who this might be right for
Malignant Pleural Effusion
Chinese PLA General Hospital 72
Large-scale testing (Phase 3)Active Not RecruitingNCT05671510
What this trial is testing

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Who this might be right for
Non Small Cell Lung Cancer
OncoC4, Inc. 630
Not applicableLooking for participantsNCT06726590
What this trial is testing

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Who this might be right for
DiabetesCholesterolCancer+6 more
Texas A&M University 3,000
Not applicableEnded earlyNCT04718610
What this trial is testing

Heart Rate Variability, Vagus Nerve and Cancer

Who this might be right for
Lung CancerColorectal CancerMultiple Myeloma+1 more
Centre Hospitalier Henri Duffaut - Avignon 25
Testing effectiveness (Phase 2)UnknownNCT02967497
What this trial is testing

Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild Type

Who this might be right for
Epithelial Growth Factor Receptor Negative Non-small Cell Lung Cancer
Taipei Veterans General Hospital, Taiwan 56
Early research (Phase 1)Study completedNCT00986297
What this trial is testing

Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center 60
Not applicableLooking for participantsNCT07827183
What this trial is testing

AI-Personalized Discharge Education for Patients After Lung Cancer Surgery

Who this might be right for
Lung Cancer (Diagnosis)
Xiamen University 156
Early research (Phase 1)UnknownNCT05826483
What this trial is testing

Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status

Who this might be right for
Malignant Tumor of LungPoor Performance Status
Guangzhou Institute of Respiratory Disease 20
Next Page